Cri-du-chat syndrome is caused by a partial deletion of the short arm of chromosome 5 and takes its name from the distinctive high-pitched, cat-like cry many babies with the condition make in infancy. It is associated with intellectual disability, significant speech and motor delays, and distinctive facial features, and it occurs in roughly 1 in 15,000 to 50,000 births. Because most people with Cri-du-chat syndrome have limited verbal communication, much of what is known about their mental health and daily wellbeing comes from caregiver-reported research. Recent studies point to three recurring themes: widespread, often undiagnosed sleep problems; psychiatric medication decisions that involve real trade-offs; and autism-related characteristics that vary more than in some other genetic syndromes.
Sleep problems that persist from childhood into adulthood
Two 2026 questionnaire-based studies from an Italian research network, conducted with families through the Associazione Bambini Cri du Chat, examined sleep across the lifespan. Among 51 children (median age 10), every single participant had a pathological score on the Child's Sleep Habits Questionnaire. Younger children showed significantly greater insomnia severity and higher scores for sleep maintenance problems and daytime sleepiness than older children (p < 0.05), and severe intellectual disability was independently associated with sleep-related arousal and breathing disorders (p = 0.016) and daytime sleepiness (p = 0.032). About 51% of children had received pharmacological treatment for sleep at some point, almost always melatonin, which caregivers rated as effective in 68% of treated cases. Among 70 adults (median age 31), poor sleep quality was detected in 49% and clinically significant insomnia in 35.7%, with sleep maintenance difficulties the most common complaint (47.1%), followed by trouble falling asleep (25.7%) and daytime sleepiness (22.9%). Many adults with sleep problems serious enough to show up on standardized scales had never received a formal sleep evaluation. After accounting for age and sex, older age was independently linked to worse sleep quality, insomnia, and daytime sleepiness, epilepsy was independently linked to greater daytime sleepiness, and severe intellectual disability was linked to more pronounced daytime behavioral disturbances.
Coping strategies for families
- Ask for a formal sleep screening, not just a general complaint. Both studies found that many caregivers were living with clinically significant sleep problems that had never been formally diagnosed. Describing specifics, such as how long it takes to fall asleep, how often nighttime waking happens, and how sleepy your family member seems during the day, can prompt the kind of evaluation that a general comment about “sleeping badly” often doesn't.
- Treat melatonin as a reasonable starting point, with a plan to reassess. Melatonin was the most commonly used sleep medication in the children's study and was rated effective in about two-thirds of cases. Discussing dose, timing, and a schedule for checking whether it's still needed can help avoid indefinite open-ended use.
- Ask whether epilepsy might be contributing to daytime sleepiness. In adults, epilepsy was independently linked to greater daytime sleepiness, separate from age or degree of intellectual disability. Coordinating seizure management with sleep care may help address fatigue that could otherwise be mistaken for a fixed trait of the condition.
- Expect sleep problems to change with age rather than disappear. Younger children showed the most severe insomnia and sleep-maintenance difficulties, while adults continued to report high rates of sleep maintenance trouble alongside different patterns of sleepiness. Plan for ongoing reassessment across the lifespan rather than a single fix.
- Build predictable routines, especially with more severe intellectual disability. Both studies linked severe intellectual disability to more pronounced sleep and daytime behavioral disturbances. Consistent, predictable bedtime and daytime routines may be especially valuable for reducing this burden.
The complexity of psychiatric medication management
A 2024 case report illustrates how delicate psychiatric medication decisions can be in Cri-du-chat syndrome. A 23-year-old nonverbal man was prescribed risperidone to manage aggressive behavior. The medication controlled the aggression but caused bilateral gynecomastia and hyperprolactinemia, a known antipsychotic side effect. When clinicians tapered the risperidone to resolve these physical symptoms, a different behavior resurfaced: excessive masturbation that the medication had previously been suppressing. Reintroducing risperidone brought the compulsive behavior back under control. The case authors describe this as a genuine balancing act rather than a simple side-effect problem, since the same medication was managing two distinct behavioral concerns at once, and stopping it to fix one issue let the other return. They emphasize that this kind of outcome calls for meticulous, ongoing monitoring and individualized treatment planning rather than quick discontinuation when a side effect appears.
An autism profile that doesn't fit a single mold
A 2023 machine-learning study examined autism-related characteristics across thirteen genetic syndromes, including 75 people with Cri-du-chat syndrome, using Social Communication Questionnaire scores from more than 1,500 individuals in total. A classification model correctly sorted 55% of participants into their syndrome group or a comparison group of autistic individuals without a known genetic syndrome. Some syndromes, including Angelman, fragile X, Prader-Willi, Rubinstein-Taybi, and Cornelia de Lange syndromes, showed distinctive autism profiles that the model could recognize fairly reliably. Cri-du-chat syndrome was among the syndromes, along with Lowe, Smith-Magenis, tuberous sclerosis complex, Sotos, and Phelan-McDermid syndromes, where autism-related characteristics overlapped more broadly with other groups and were less syndrome-specific. The authors argue this calls for more individualized assessment of autism characteristics in Cri-du-chat syndrome rather than assuming a single generic profile applies to everyone with the diagnosis.
Practical tips for families and care teams
- Bring validated questionnaires, not just general impressions, to appointments. Simple caregiver-report tools covering sleep habits, insomnia severity, and daytime sleepiness can turn a vague sense that “sleep is hard” into specific, actionable clinical detail.
- Discuss medication trade-offs explicitly before tapering a dose. The risperidone case shows that stopping a medication to resolve one side effect can let a previously controlled behavior reemerge. Ask what to watch for, and over what timeframe, before any planned change.
- Request individualized autism assessment rather than a generic syndrome profile. Because Cri-du-chat syndrome's autism-related characteristics are less distinctive than in some other genetic syndromes, each person's profile may benefit from dedicated, individualized evaluation.
- Revisit sleep plans as your child or family member ages. The same underlying condition produced different sleep patterns in children versus adults in these studies, so routines and treatments that worked at one life stage may need adjustment at another.
- Loop in neurology if epilepsy is part of the picture. Epilepsy showed an independent link to daytime sleepiness in adults. Coordinated care across neurology and sleep medicine can help address fatigue that might otherwise be attributed only to intellectual disability.